These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1450204)

  • 21. Liposomes can function as targets for natural killer cytotoxic factor but not for tumor necrosis factor.
    Roozemond RC; Urli DC; Jansen J; Bonavida B
    J Immunol; 1989 Feb; 142(4):1209-16. PubMed ID: 2915117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomes as carrier and immunoadjuvant of vaccine antigens.
    van Rooijen N
    Adv Biotechnol Processes; 1990; 13():255-79. PubMed ID: 2185785
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposomes.
    Watarai S; Han M; Tana ; Kodama H
    J Vet Med Sci; 1998 Sep; 60(9):1047-50. PubMed ID: 9795911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Endosomal Escape and Degradation of α-Galactosylceramide Loaded Liposomes on CD1d Antigen Presentation.
    Nakamura T; Kuroi M; Harashima H
    Mol Pharm; 2015 Aug; 12(8):2791-9. PubMed ID: 26107189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens.
    Fortin A; Shahum E; Krzystyniak K; Thérien HM
    Cell Immunol; 1996 May; 169(2):208-17. PubMed ID: 8620548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for direct control of an in vitro plaque-forming cell response by quantitative properties of intact, fluid, haptenated liposomes: a potential model system for antigen presentation by macrophages.
    Humphries GM
    J Immunol; 1981 Feb; 126(2):688-92. PubMed ID: 6161186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
    Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
    Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.
    Alving CR; Wassef NM
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S91-4. PubMed ID: 7532427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes.
    Zhou F; Watkins SC; Huang L
    Immunobiology; 1994 Feb; 190(1-2):35-52. PubMed ID: 8082886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen presentation by liposomes bearing class II MHC and membrane IL-1.
    Bakouche O; Lachman LB
    Yale J Biol Med; 1990; 63(2):95-107. PubMed ID: 2399741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen presenting cells and mechanisms of antigen presentation.
    Chesnut RW; Grey HM
    Crit Rev Immunol; 1985; 5(3):263-316. PubMed ID: 3884274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid A and liposomes containing lipid A as antigens and adjuvants.
    Alving CR; Rao M
    Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The macrophage as the principal antigen-presenting cell for liposome-encapsulated antigen.
    Szoka FC
    Res Immunol; 1992 Feb; 143(2):186-8. PubMed ID: 1574644
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of glycolipids on immune reactions of phospholipid antigens in liposomes.
    Shichijo S; Alving CR
    Biochim Biophys Acta; 1985 Nov; 820(2):289-94. PubMed ID: 4052424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antigen processing and antigen presentation by accessory cells of the immune system].
    Langner J
    Allerg Immunol (Leipz); 1985; 31(3):131-56. PubMed ID: 2416210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of temperature on complement-dependent immune damage to liposomes.
    Alving CR; Urban KA; Richards RL
    Biochim Biophys Acta; 1980 Jul; 600(1):117-25. PubMed ID: 6156699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trafficking of liposomal antigens to the trans-Golgi complex in macrophages.
    Rao M; Rothwell SW; Alving CR
    Methods Enzymol; 2003; 373():16-33. PubMed ID: 14714394
    [No Abstract]   [Full Text] [Related]  

  • 38. Isopranoid- and dipalmitoyl-aminophospholipid adjuvants impact differently on longevity of CTL immune responses.
    Dicaire CJ; Yu SH; Whitfield DM; Sprott GD
    J Liposome Res; 2010 Dec; 20(4):304-14. PubMed ID: 20148707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen processing and presentation: modelling with Leishmania.
    Kaye PM; Curry AJ; Bancroft GJ; Lang T
    Behring Inst Mitt; 1991 Feb; (88):13-9. PubMed ID: 2049030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospholipid membranes form specific nonbilayer molecular arrangements that are antigenic.
    Aguilar L; Ortega-Pierres G; Campos B; Fonseca R; Ibáñez M; Wong C; Farfán N; Naciff JM; Kaetzel MA; Dedman JR; Baeza I
    J Biol Chem; 1999 Sep; 274(36):25193-6. PubMed ID: 10464237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.